Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters











Publication year range
1.
J Neuroimmunol ; 363: 577789, 2022 02 15.
Article in English | MEDLINE | ID: mdl-34973472

ABSTRACT

OBJECTIVE: The aim of this case report was to describe a potential anti-interleukin (IL)-6 treatment for cryptogenic new-onset refractory status epilepticus (C-NORSE). BACKGROUND: Although an underlying immune-mediated pathogenesis is considered present in some C-NORSE cases, many cases do not respond to classical immunotherapies. CASE REPORT: We describe the case of a 46-year-old woman with C-NORSE who achieved cessation of long-lasting status epilepticus following administration of tocilizumab, an IL-6 receptor-blocking antibody, although the final outcome was poor. CONCLUSIONS: Anti-IL-6 treatment may prove effective in stopping status epilepticus in some C-NORSE cases.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Drug Resistant Epilepsy/drug therapy , Interleukin-6/antagonists & inhibitors , Status Epilepticus/drug therapy , Female , Humans , Middle Aged
3.
Rinsho Shinkeigaku ; 61(4): 258-261, 2021 Apr 21.
Article in Japanese | MEDLINE | ID: mdl-33762494

ABSTRACT

We report a 47-year-old woman who presented with progressive myalgia, weakness in the proximal limbs, and dysphagia for a month and a half. No skin rash was observed on admission. Examination of MRI data suggested inflammatory changes in the proximal limbs and trunk muscles. Biopsy specimens from the left biceps muscle showed no perifascicular atrophy, but immunohistochemical staining revealed the presence of myxovirus resistance protein A (MxA) in myofibers, strongly suggesting dermatomyositis (DM). In addition, her serum was positive for anti-nuclear matrix protein 2 (anti-NXP-2) antibody, which is reportedly useful as a marker of DM without skin lesions. Her symptoms gradually improved upon intravenous methylprednisolone pulse therapy in conjunction with oral prednisolone, oral tacrolimus, and intravenous immunoglobulin therapy. Our findings suggest that in cases where inflammatory muscle disease is suspected, anti-NXP-2 antibody analyses should be considered for precise diagnosis, even if there are no dermatological symptoms.


Subject(s)
Adenosine Triphosphatases/immunology , Antibodies, Antinuclear/metabolism , DNA-Binding Proteins/immunology , Dermatomyositis/diagnosis , Dermatomyositis/immunology , Asymptomatic Diseases , Biomarkers/metabolism , Female , Humans , Middle Aged , Muscle, Skeletal/metabolism , Myxovirus Resistance Proteins/metabolism
4.
Rinsho Shinkeigaku ; 59(3): 153-156, 2019 Mar 28.
Article in Japanese | MEDLINE | ID: mdl-30814443

ABSTRACT

We analyzed 14 patients in our hospital, who underwent levodopa-carbidopa intestinal gel (LCIG) treatment through a percutaneous endoscopic gastrojejunostomy (PEG-J). The PEG-J related complications were observed in 10 patients (71.4%). Detailed complications are as followings: J-tube related complications such as kinking (3 cases, 21.4%), pump malfunctions (3 cases, 21.4%), skin troubles in the gastrostoma (7 cases, 50.0%), duodenal perforation, peritonitis, and ulcers (2 cases, 14.3%). These results indicated that the sufficient care for PEG-J associated complications are important in LCIG treatment.


Subject(s)
Antiparkinson Agents/administration & dosage , Carbidopa/administration & dosage , Endoscopy, Gastrointestinal/adverse effects , Gastrostomy/adverse effects , Jejunostomy/adverse effects , Levodopa/administration & dosage , Parkinson Disease/drug therapy , Adult , Aged , Drug Combinations , Duodenal Diseases/epidemiology , Duodenal Diseases/etiology , Duodenal Ulcer/epidemiology , Duodenal Ulcer/etiology , Endoscopy, Gastrointestinal/instrumentation , Endoscopy, Gastrointestinal/methods , Female , Gastrostomy/instrumentation , Gastrostomy/methods , Gels , Humans , Intestinal Perforation/epidemiology , Intestinal Perforation/etiology , Jejunostomy/instrumentation , Jejunostomy/methods , Male , Middle Aged , Peritonitis/epidemiology , Peritonitis/etiology , Retrospective Studies , Skin Diseases/epidemiology , Skin Diseases/etiology , Surgical Stomas
5.
Epilepsy Behav ; 92: 145-153, 2019 03.
Article in English | MEDLINE | ID: mdl-30660057

ABSTRACT

PURPOSE: Cavernous malformation (CM) in the temporal neocortex causes intractable epilepsy. Whether to resect additional mesial temporal structures in addition to the lesionectomy is a still controversial issue. To clarify the need for the procedure, we retrospectively analyzed pre- and postoperative clinical data of patients with surgically removed CM. SUBJECTS AND METHODS: We included data from 18 patients with CM in the temporal neocortex who presented with intractable epilepsy. Eleven patients of our early series were treated with extended resection, i.e., lesionectomy and the resection of additional mesial temporal structures. Seven patients underwent lesionectomy, i.e., removal of the CM and of hemosiderin-stained surrounding brain tissue. Pathological assessments of the resected hippocampus were performed. Chronic intracranial electroencephalography (EEG) recordings were obtained in 6 patients. We performed perioperative neuropsychological assessments in all patients. RESULTS: The seizure outcome was recorded as Engel class I in 17 patients (94.4%); Ia = 12 (66.7%) Ib = 2 (11.1%), Ic = 1 (5.6%), Id = 2 (11.1%), and class IIb in one patient (5.6%). Adding resection of the mesial temporal structures to lesionectomy did not alter the seizure outcome. Pathology of hippocampus revealed limited neuronal loss in CA4. Ictal onsets in the ipsilateral lateral cortex were detected in all 6 patients who underwent intracranial EEG. In 4 patients each, we also detected ictal onsets from the ipsilateral mesial temporal structures and from the contralateral temporal lobe. Postoperatively, in the patients where their CM was located in the language-dominant hemisphere (n = 10), the full-scale intelligence quotient (IQ) and the performance IQ increased (p < 0.05), whereas the verbal memory (WMS-R) deteriorated in two of 5 patients. CONCLUSION: Excellent seizure outcomes were obtained even the lesionectomy alone. To confirm appropriate surgical strategy for lateral temporal CM with intractable epilepsy, further studies in large sample size are needed.


Subject(s)
Drug Resistant Epilepsy/surgery , Epilepsy, Temporal Lobe/surgery , Hemangioma, Cavernous, Central Nervous System/surgery , Neocortex/surgery , Seizures/surgery , Temporal Lobe/surgery , Adult , Drug Resistant Epilepsy/complications , Drug Resistant Epilepsy/pathology , Drug Resistant Epilepsy/physiopathology , Electroencephalography/adverse effects , Epilepsy, Temporal Lobe/complications , Female , Hemangioma, Cavernous, Central Nervous System/complications , Hippocampus/pathology , Hippocampus/physiopathology , Hippocampus/surgery , Humans , Male , Middle Aged , Retrospective Studies , Seizures/complications , Seizures/pathology , Seizures/physiopathology , Temporal Lobe/pathology , Temporal Lobe/physiopathology , Young Adult
6.
Rinsho Shinkeigaku ; 58(9): 570-573, 2018 Sep 28.
Article in Japanese | MEDLINE | ID: mdl-30175807

ABSTRACT

A 68-year-old man, who had received Billroth II gastrojejunostomy because of duodenal ulcer at the age of 20, was diagnosed to have Parkinson's disease at age 57 years. The drug therapy has been effective in the first 10 years, however, recently he was suffering from troublesome dyskinesia and wearing-off in spite of diligent drug adjustments. Although the indication of levodopa-carbidopa intestinal gel (LCIG) treatment was good, percutaneous endoscopic gastrostomy was difficult because of abdominal adhesion. Therefore, we introduced LCIG by surgical gastrostomy. After LCIG therapy, wearing-off and dyskinesia disappeared. This is the first case of Parkinson's disease patient with LCIG therapy by surgical gastrostomy in Japan.


Subject(s)
Antiparkinson Agents/administration & dosage , Carbidopa/administration & dosage , Gastric Bypass , Gastrostomy , Levodopa/administration & dosage , Parkinson Disease/drug therapy , Aged , Dosage Forms , Drug Combinations , Drug Compounding , Duodenal Ulcer/surgery , Gels , Humans , Male , Treatment Outcome
7.
J Clin Neurophysiol ; 34(5): 427-433, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28557904

ABSTRACT

PURPOSE: Focal cortical dysplasia (FCD) is intrinsically epileptogenic, and an MRI-visible lesion typically constitutes the core part of the epileptogenic zone. We aimed to identify ictal EEG patterns that represent the epileptogenic zone by using subdural electrodes placed over the MRI-visible FCD lesion. METHODS: We selected seven patients with frontal lobe epilepsy caused by pathologically proven FCD type IIb who underwent preoperative intracranial EEG evaluation with subdural electrodes followed by resection surgery with seizure-free outcome. The characteristics of ictal EEG patterns, interictal/ictal high-frequency oscillations, and ictal direct current shifts from intracranial electrodes placed over the MRI-visible lesion were analyzed. RESULTS: Two seizure-onset patterns (low voltage fast activity and fast spike activity) were identified. Low voltage fast activity was seen in all patients with a lateral frontal lesion, and it was always preceded by preictal spikes. Fast spike activity occurred only in patients with a mesial frontal lesion. Interictal/ictal high-frequency oscillations and ictal direct current shifts were seen in all patients. CONCLUSIONS: The epileptogenic zone of frontal FCD type IIb may be characterized by EEG seizure-onset patterns consisting of low voltage fast activity and fast spike activity accompanied by ictal high-frequency oscillations and ictal direct current shifts. Further study is needed to determine whether other seizure-onset patterns exist in patients with FCD type IIb.


Subject(s)
Electrocorticography/methods , Epilepsy/physiopathology , Frontal Lobe/abnormalities , Frontal Lobe/physiopathology , Malformations of Cortical Development, Group I/physiopathology , Adult , Epilepsy/complications , Epilepsy/etiology , Female , Humans , Male , Malformations of Cortical Development, Group I/complications , Middle Aged , Young Adult
8.
J Clin Neurophysiol ; 33(6): 564-568, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27295331

ABSTRACT

PURPOSE: Diagnosis of amyotrophic lateral sclerosis (ALS) at an early stage is challenging, thus making the enrollment of these patients in clinical trials infeasible. In this study, we investigated the potential usability of motor unit number index (MUNIX) to detect denervation of clinically intact muscles of ALS patients. METHODS: Thirty-two first dorsal interosseous muscles of 26 ALS patients were evaluated with both MUNIX and needle electromyography. RESULTS: The mean MUNIX value of first dorsal interosseous muscles was 131 in the control group, whereas it was 48, 34, 15, and 8 for Medical Research Council scales of 5, 4, 3, and 2, respectively, in the ALS patients. The optimal cutoff point gave a sensitivity of 0.89 and a specificity of 1.0. Among 9 intact first dorsal interosseous muscles of the ALS patients, 8 showed MUNIX values below the cutoff point, whereas only 2 first dorsal interosseous muscles showed denervation on needle electromyography. CONCLUSIONS: MUNIX could serve as a sensitive technique to detect denervation of clinically intact muscles of ALS patients.


Subject(s)
Evoked Potentials, Motor/physiology , Muscle, Skeletal/innervation , Muscle, Skeletal/physiopathology , Adult , Aged , Aged, 80 and over , Amyotrophic Lateral Sclerosis/diagnosis , Electromyography , Female , Humans , Male , Middle Aged , Neural Conduction/physiology
10.
Rinsho Shinkeigaku ; 54(3): 223-6, 2014.
Article in Japanese | MEDLINE | ID: mdl-24705837

ABSTRACT

We report a case of reversible hepatic myelopathy. A 42-year-old female patient with 3-year history of alcoholic liver cirrhosis developed spastic gait, hyperreflexia and mild somatosensory disturbance in her lower extremities. The increased level of serum ammonia and the deficits of N30 and P38 in the tibial somatosensory evoked potentials (SEP) in conjunction with exclusion of the other known causes of myelopathy supported the diagnosis of her hepatic myelopathy. The ammonia lowering therapy by the oral administration of lactulose successfully improved the spastic gait accompanied with the emergence of N30 and P38 in the tibial SEP. Although liver transplantation was known to be the only therapy for hepatic myelopathy in the literatures, our case showed that the ammonia lowering therapy can be effective for the early stage of hepatic myelopathy.


Subject(s)
Gastrointestinal Agents/administration & dosage , Lactulose/administration & dosage , Liver Cirrhosis, Alcoholic/complications , Spinal Cord Diseases/drug therapy , Spinal Cord Diseases/etiology , Administration, Oral , Adult , Ammonia/blood , Biomarkers/blood , Evoked Potentials, Somatosensory , Female , Humans , Hyperammonemia/drug therapy , Hyperammonemia/etiology , Liver Transplantation , Spinal Cord Diseases/diagnosis , Tibia/physiopathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL